.

BioPharmaceutical Business Intelligence

  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
  • Drug patents in 130+ countries

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Moodys
Argus Health
Johnson and Johnson
Chinese Patent Office
Cipla
Queensland Health
Boehringer Ingelheim
Mallinckrodt
Citi

Generated: December 15, 2017

DrugPatentWatch Database Preview

Details for Patent: 8,349,294

« Back to Dashboard

Which drugs does patent 8,349,294 protect, and when does it expire?


Patent 8,349,294 protects TOBI PODHALER and is included in one NDA.

This patent has one hundred and forty-nine patent family members in thirty-seven countries.

Summary for Patent: 8,349,294

Title:Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use
Abstract: Microparticle compositions comprising metal ion-lipid complexes for drug delivery are described including methods of making the microparticle compositions and methods of treating certain conditions and disease states by administering the microparticle compositions. The metal ion-lipid complexes can be combined with various drugs or active agents for therapeutic administration. The microparticle compositions of the present invention have superior stability to other microparticle compositions resulting in a microparticle composition with longer shelf life and improved dispersability. The microparticle compositions of the present invention have a transition temperature (T.sub.g) of at least 20.degree. C. above the recommended storage temperature (Tst) for drug delivery.
Inventor(s): Dellamary; Luis A (San Marcos, CA), Riess; Jean (Falicon, FR), Schutt; Ernest G (San Diego, CA), Weers; Jeffry G (Belmont, CA), Tarara; Thomas E (Burlingame, CA)
Assignee: Novartis AG (Basel, CH)
Application Number:12/967,482
Patent Claim Types:
see list of patent claims
Composition; Delivery;

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
NovartisTOBI PODHALERtobramycinPOWDER;INHALATION201688-001Mar 22, 2013RXYesYes► Subscribe► Subscribe► SubscribeY
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

Non-Orange Book Patents for Patent: 8,349,294

For Orange Book-listed patents (shown in the main table above) generic applications must certify that the listed patents are expired, invalid, or will not be infringed by generic entry.

The non-Orange Book patents listed below do not require formal certifications, so they do not automatically impede generic entry. Instead, they represent potential opportunities for branded firms to block generic entry through patent infringment challenges.

Patent No. Title Estimated Patent Expiration
8,246,934Respiratory dispersion for metered dose inhalers comprising perforated microstructures► Subscribe
8,080,263Dispersion for pulmonary delivery of a bioactive agent► Subscribe
7,205,343Stabilized bioactive preparations and method of use► Subscribe
8,513,204Compositions comprising amphotericin B, mehods and systems► Subscribe
7,871,598Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery and methods of use► Subscribe
7,473,433Pulmonary delivery of polyene antifungal agents► Subscribe
6,309,623 Stabilized preparations for use in metered dose inhalers► Subscribe
8,877,162Stable metal ion-lipid powdered pharmaceutical compositions for drug delivery► Subscribe
9,554,993Pulmonary delivery particles comprising an active agent► Subscribe
7,306,787Engineered particles and methods of use► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Because of the complexity of determining patent expiration dates it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

International Patent Family for Patent: 8,349,294

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Japan2003525841► Subscribe
Iceland5415► Subscribe
Japan2001517692► Subscribe
Japan6100114► Subscribe
Japan2013199497► Subscribe
Japan6078498► Subscribe
Japan2014169335► Subscribe
Japan5952231► Subscribe
Japan2013237681► Subscribe
Japan5739197► Subscribe
This preview shows a limited data set
Subscribe for full access, or try a Trial

The estimated expiration dates shown above are derived by simply adding 20 years to the priority date.
Due to the complexity of determining patent expirations even in a single country, compounded by the diversity of global patent laws, it is advisable to have patent counsel verify freedom to operate.

Export unavailable in trial.
Subscribe for complete access.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Queensland Health
Dow
Federal Trade Commission
Cipla
Novartis
Harvard Business School
Johnson and Johnson
Citi
AstraZeneca
Julphar

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot